Digital healthcare came into its own when COVID-19 began to take its toll, and no one was more ready than telehealth brand Hims & Hers. The recent startup pivoted from its origins (it was founded in 2017 selling products and services for specific categories such as sexual health and hair loss) into providing a broader range of home healthcare offerings, including at-home coronavirus test kits, primary care in English and Spanish, telepsychiatry and free online support groups.
As a result, Hims & Hers experienced unprecedented growth, conducting nearly one million telehealth consultations during the first half of 2020 and seeing a 67% increase in revenue growth from 2019 to 2020. In January 2021, it went public on the New York Stock Exchange. The brand prides itself on its consumer-centric approach, from its user-friendly website to product display, and says it will continue to disrupt the healthcare system even as we come out of the pandemic.